<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Pulsenmore Ltd. — News on 6ix</title>
<link>https://6ix.com/company/pulsenmore-ltd-1</link>
<description>Latest news and press releases for Pulsenmore Ltd. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 30 Mar 2026 12:29:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/pulsenmore-ltd-1" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d590c3beedb30cb6f8f7ce.webp</url>
<title>Pulsenmore Ltd.</title>
<link>https://6ix.com/company/pulsenmore-ltd-1</link>
</image>
<item>
<title>Pulsenmore Announces Full Year 2025 Financial Results and Webcast</title>
<link>https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-announces-full-year-2025-financial-results-and-webcast</link>
<guid isPermaLink="true">https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-announces-full-year-2025-financial-results-and-webcast</guid>
<pubDate>Mon, 30 Mar 2026 12:29:00 GMT</pubDate>
<description>Pulsenmore Announces Full Year 2025 Financial Results and Webcast</description>
</item>
<item>
<title>Pulsenmore Announces Full Year 2025 Earnings Conference Call</title>
<link>https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-announces-full-year-2025-earnings-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-announces-full-year-2025-earnings-conference-call</guid>
<pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
<description>Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it will release its financial results for full year 2025 on March 30, 2026 at 8:30 a.m. EST.</description>
</item>
<item>
<title>Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance</title>
<link>https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-builds-us-momentum-with-another-commercial-engagement-following-fda-clearance</link>
<guid isPermaLink="true">https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-builds-us-momentum-with-another-commercial-engagement-following-fda-clearance</guid>
<pubDate>Mon, 09 Feb 2026 12:00:00 GMT</pubDate>
<description>Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a new commercial engagement with TLC Perinatal PA, a maternal-fetal medicine and women's ultrasound practice in Maryland, as part of its growing U.S. rollout.</description>
</item>
<item>
<title>Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center</title>
<link>https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-announces-first-commercial-engagement-with-a-leading-us-based-medical-center</link>
<guid isPermaLink="true">https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-announces-first-commercial-engagement-with-a-leading-us-based-medical-center</guid>
<pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
<description>Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in the United States, following receipt of FDA approval for its home pregnancy ultrasound product.</description>
</item>
<item>
<title>Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation</title>
<link>https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-and-clalit-health-services-launch-first-at-home-follicular-monitoring-service-for-ivf-and-fertility-preservation</link>
<guid isPermaLink="true">https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-and-clalit-health-services-launch-first-at-home-follicular-monitoring-service-for-ivf-and-fertility-preservation</guid>
<pubDate>Mon, 26 Jan 2026 12:30:00 GMT</pubDate>
<description>Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a global leader in connected home ultrasound technology, today announced an additional strategic commercial agreement with Clalit Health Services, Israel's largest health maintenance organization (HMO), to supply Pulsenmore FC, a new at-home ultrasound solution designed for remote follicular monitoring in women undergoing fertility care (IVF and fertility preservation). The agreement is potentially valued at approximately $ 4.5 million over five years</description>
</item>
<item>
<title>Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.</title>
<link>https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-to-commence-trading-on-nasdaq-as-it-expands-fda-authorized-home-prenatal-ultrasound-devices-in-the-us-1</link>
<guid isPermaLink="true">https://6ix.com/company/pulsenmore-ltd-1/news/pulsenmore-to-commence-trading-on-nasdaq-as-it-expands-fda-authorized-home-prenatal-ultrasound-devices-in-the-us-1</guid>
<pubDate>Wed, 21 Jan 2026 12:30:00 GMT</pubDate>
<description>Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that its shares will begin trading on Nasdaq at the U.S. market open today. The Company's shares will trade under the ticker symbol PLSM on the Nasdaq Capital Market as well as the Tel Aviv Stock Exchange (TASE).</description>
</item>
</channel>
</rss>